UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018330
Receipt number R000021213
Scientific Title The bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human
Date of disclosure of the study information 2015/07/16
Last modified on 2017/01/16 13:41:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human

Acronym

The bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human

Scientific Title

The bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human

Scientific Title:Acronym

The bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human

Region

Japan


Condition

Condition

healthy volunteer

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the bradycardiac effect and safety of magnetic vagal nerve stimulation in healthy human

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

heart rate
blood pressure

Key secondary outcomes

Safety


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

magnetic stimulation 5 Hz, 3 min

Interventions/Control_2

magnetic stimulation 20 Hz, 3 min

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >

Gender

Male and Female

Key inclusion criteria

Person who are between the ages of 21 and 60
Person without history of atrial fibrillation
Person without had implanted cardiac pacemaker
Person without taking cardiovascular agent
Person who applied for the subject solicitation
Subjects who could make self-judgment and were voluntarily giving written informed consent

Key exclusion criteria

Person who are diagnosed with bradycardia (<=50bpm)
Person who is suspected to have an autonomic dysfunction
Person who is pregnant or lactating
Person judged as unsuitable for the study by the investigator

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ide Tomomi

Organization

Kyushu University

Division name

Department of Cardiovascular Medicine, Graduate School of Medical Sciences

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5360

Email

tomomi_i@cardiol.med.kyushu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Saku Keita

Organization

Kyushu University

Division name

Department of Therapeutic Regulation of Cardiovascular Homeostasis, Center for Disruptive Cardiovasc

Zip code


Address

3-1-1 Maidashi, Higashi-ku, Fukuoka

TEL

092-642-5360

Homepage URL


Email

saku@cardiol.med.kyushu-u.ac.jp


Sponsor or person

Institute

Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 07 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 25 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 07 Month 16 Day

Last modified on

2017 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021213


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name